BioSpace News Archive

Key findings presented at AAIC 2020 include: a need to improve patients’ symptoms and ability to know what is real versus what is not real

Jubilant Biosys Limited (“Biosys”), a wholly owned subsidiary of Jubilant Life Sciences Limited, today announced completion of the merger with its sister company Jubilant Chemsys Limited, based in Noida, India.

The Pershing Square Sohn Cancer Research Alliance today announced the seven winners of the 2020 Pershing Square Sohn Prize for Young Investigators in Cancer Research, awarded annually to cancer research scientists and physician-scientists based in the greater New York-area.

Findings offer first-time evidence of neuro-axonal damage in mild-to-moderate cases of SARS-CoV-2 and validate serum neurofilament light chain (sNfL) as a highly specific biomarker to measure and monitor damage during and post infection BILLERICA, Mass.--( BUSINESS WIRE )-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that quantitative testing using its sN

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today commented on the initial results of researc

Micron Medical, a privately-held medical device company engaged in the development, manufacture and pre-commercialization of innovative wireless, minimally invasive, electroceutical solutions for urological conditions, today announced that Stephen Deitsch, Chief Executive Officer, and Laura Perryman, Inventor and Chief Operating Officer, will present a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by Li

Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that TrueBinding, Inc. (“TrueBindi

Alarming new data shows the disturbing trend within the diabetes population in the U.S. of high unemployment and worsening health outcomes as they are severely and disproportionately impacted by the COVID-19 pandemic.

ADVANZ PHARMA Corp. Limited (“ADVANZ PHARMA” or “the Company”), an international specialty pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, today announced it intends to release its second quarter, 2020 financial results before market open on Wednesday, August 12, 2020.

Tychan, a Singapore-based clinical-stage biotechnology company focused on developing life-saving treatments through disruptive technologies, announced today a publication in New England Journal of Medicine (NEJM) demonstrating the safety and efficacy for TY014, a novel monoclonal antibody candidate treatment for yellow fever (YF).